<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250812066842N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-08-16</date_registration>
      <primary_sponsor>Razi University</primary_sponsor>
      <public_title>Non-invasive brain stimulation and Endurance function</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the Effects of Transcranial Direct and Pulsed Current Stimulation on Endurance and Cognitive Performance in Physical Education Students</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>15</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/85516</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Crossover, Purpose: Supportive, Randomization description: To randomize the order in which participants are exposed to the three conditions in this study, a Latin square design will be employed. For this purpose, each participant will first be assigned a unique identification number between 1 and 15 using the website www.random.org. Next, the letters B, A, and C will be assigned to the three intervention conditions, and a Latin square will be constructed. In this configuration, a Latin square with three rows and three columns will be created. Finally, participants numbered 1 to 5 will follow the sequence in the first row, participants numbered 6 to 10 will follow the sequence in the second row, and participants numbered 11 to 15 will follow the sequence in the third row, Blinding description: Both the participants and the principal investigator will be blinded to the type of stimulation received in each session. This information will remain accessible only to an individual outside the research team until the completion of the study. To maintain blinding of the stimulation order from the principal investigator, all procedures related to the random assignment of stimulation sequences for each participant will be conducted by this external individual. Additionally, to blind participants to the type of stimulation in each session, the tDCS device will be concealed from view using a cover, and the principal investigator will not be present in the laboratory during electrode placement, throughout the 20-minute stimulation period, or during electrode removal.</study_design>
      <phase>N/A</phase>
      <hc_freetext>This study involves healthy male physical education students aged 18–29 years with no cardiovascular, pulmonary, metabolic, neurological, musculoskeletal, or visual disorders. The research does not study a specific disease but examines neuromodulation effects on endurance and cognitive performance in a healthy, physically active population..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1:  Participants will receive anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex (L-DLPFC) with the anode at F3 and the cathode at AF4, at 2 mA intensity for 20 minutes. Intervention 2: Intervention group 2:  Participants will receive anodal transcranial pulsed current stimulation (tPCS) over the left dorsolateral prefrontal cortex (L-DLPFC) with the same electrode placement, at 1.5 mA intensity for 20 minutes. Intervention 3: Control group:  Participants will receive sham stimulation with identical electrode placement; however, current will be delivered for only the first 30 seconds and then stopped, mimicking the sensation without providing actual stimulation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Vahid Tadibi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Razi University, Bagh Abrisham blvd</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714414874</zip>
        <telephone>+98 83 3427 7609</telephone>
        <email>vtadibi@yahoo.com</email>
        <affiliation>Razi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Vahid Tadibi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Razi University, Bagh Abrisham blvd</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714414874</zip>
        <telephone>+98 83 3427 7609</telephone>
        <email>vtadibi@yahoo.com</email>
        <affiliation>Razi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range: 18–29 years
Male physical education students at Razi University, third semester or higher
Body mass index (BMI): 18.5–24.9 kg/m²
Right-handed</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>29 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Presence of any cardiovascular, pulmonary, or metabolic disease
History of seizures, epilepsy, or other neurological disorders
Presence of implanted medical devices or pacemakers
Use of tobacco or alcohol
Color blindness or other visual impairments</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1:  Participants will receive anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex (L-DLPFC) with the anode at F3 and the cathode at AF4, at 2 mA intensity for 20 minutes.</i_keyword>
      <i_keyword>Intervention group 2:  Participants will receive anodal transcranial pulsed current stimulation (tPCS) over the left dorsolateral prefrontal cortex (L-DLPFC) with the same electrode placement, at 1.5 mA intensity for 20 minutes.</i_keyword>
      <i_keyword>Control group:  Participants will receive sham stimulation with identical electrode placement; however, current will be delivered for only the first 30 seconds and then stopped, mimicking the sensation without providing actual stimulation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The primary outcome variable is the endurance performance, specifically measured as the time to exhaustion on ergometer cycling test. This is the main variable expected to change as a result of the interventions (tDCS, tPCS, or sham), and it is the outcome used for calculating the sample size. Timepoint: The primary outcome (endurance performance – time to exhaustion) is measured once in each experimental session, immediately after the application of the intervention (tDCS, tPCS, or sham). There is no multiple follow-up measurements planned — the timepoint is directly after intervention within the same session. Method of measurement: The primary outcome variable, namely endurance performance, will be assessed using a cycling test time to exhaustion on a cycle ergometer (Cyclus). During the initial session, participants’ peak power output will be determined by performing an incremental exercise test. In the three main experimental sessions, participants will be required to cycle at 85% of their determined peak power output until exhaustion, and the time to exhaustion will be recorded as the indicator of endurance performance.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Razi University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-07-02</approval_date>
        <contact_name>Ethics committee of Razi University</contact_name>
        <contact_address>Razi University, Bagh Abrisham blvd, Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
